cardiomyopathy: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
224 |
4. Check minimum number of eventsNone |
224 |
5. Include endpointsNone |
224 |
6. Filter based on genotype QC (FinnGen only) |
224 |
Control definitions (FinnGen only)
- Control exclude
- I9_OTHHEART
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Cardiomyopathies, Secondary/extrinsic
based on the number of shared cases.
Similar with more cases:
- Cardiomyopathy (excluding other)
- Cardiomyopathy
- Other heart diseases
- Other heart diseases, wide
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4781 | 746 | 3926 |
| Only index persons | 2094 | 381 | 1713 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.02 | 0.11 |
| Only index persons | 0.06 | 0.01 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 56.51 | 59.10 | 55.87 |
| Only index persons | 58.60 | 60.45 | 58.19 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 224 | 65 | 159 |
| Unadjusted period prevalence (%) | 0.06 | 0.02 | 0.07 |
| Median age at first event (years) | 60.19 | 55.59 | 62.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 200
- Matched controls
- 1998
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I42.6
ICD-10 Finland
Alcoholic cardiomyopathy
+∞
156.5
129
*
I50.9
ICD-10 Finland
Heart failure, unspecified
319.7
94.4
89
5
I42.0
ICD-10 Finland
Dilated cardiomyopathy
+∞
88.2
78
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
119.6
77.2
80
11
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
+∞
71.1
64
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
69.3
58.7
66
14
I50.1
ICD-10 Finland
Left ventricular failure
+∞
54.7
50
*
I50.0
ICD-10 Finland
Congestive heart failure
330.4
51.6
50
*
C01AA05
ATC
digoxin; systemic
55.0
50.4
59
15
C03CA01
ATC
furosemide; systemic
10.9
49.0
118
233
C03DA01
ATC
spironolactone; oral
18.4
46.0
75
63
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
+∞
43.3
40
*
207
Kela drug reimbursment
Chronic arrhythmias
460.1
39.5
38
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
112.7
35.0
37
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
9.7
31.3
70
105
B01AA03
ATC
warfarin; systemic
9.6
29.7
66
97
C07AB07
ATC
bisoprolol; oral
5.7
29.3
127
466
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
27.7
26
*
I47.2
ICD-10 Finland
Ventricular tachycardia
+∞
23.4
22
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
258.0
23.1
23
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
258.0
23.1
23
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
22.3
21
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
5.8
21.9
72
177
K78
ICPC
Atrial fibrillation/flutter
30.9
20.6
27
10
C09DX04
ATC
valsartan and sacubitril; oral
+∞
20.1
19
*
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
20.1
19
*
C09AA05
ATC
ramipril; oral
4.5
19.4
85
280
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.9
19.4
60
135
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.1
19.1
45
69
C01BD01
ATC
amiodarone; systemic
208.5
18.9
19
*
TFP20
NOMESCO Finland
Cardiodefibrillation
73.5
18.1
20
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
9.9
17.1
35
42
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
+∞
15.8
15
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.8
15.8
58
155
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
14.8
14
*
K70.0
ICD-10 Finland
Alcoholic fatty liver
24.5
14.5
20
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
14.3
50
126
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
12.2
13.4
24
22
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
+∞
12.6
12
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
138.1
12.6
13
*
GD1LA
NOMESCO Finland
GD
138.1
12.6
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.2
12.5
26
32
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
24.6
11.8
16
7
AN1
HP
Coronary angiography
4.7
11.1
39
97
P15
ICPC
Chronic alcohol abuse
11.5
10.5
19
18
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
115.7
10.5
11
*
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
115.7
10.5
11
*
N07BB01
ATC
disulfiram; oral
7.3
9.8
23
35
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
18.6
9.5
14
8
A12BA01
ATC
potassium chloride; oral
10.3
9.5
18
19
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
+∞
9.4
9
*
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
+∞
9.4
9
*
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
9.4
9
*
A98
ICPC
Health maint/preventive medicine
0.4
9.2
124
1634
K77
ICPC
Heart failure
38.5
9.1
11
*
Z2221
NOMESCO Finland
Medical doctor
2.9
9.0
62
264
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
14.9
8.8
14
10
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
14.9
8.8
14
10
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.0
8.7
21
33
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.3
8.7
15
13
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
+∞
8.4
8
*
I48.1
ICD-10 Finland
Persistent atrial fibrillation
+∞
8.4
8
*
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
8.4
8
*
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
+∞
8.4
8
*
4258A
ICD-9 Finland
Cardiomyopathy in other diseases classified elsewhere
+∞
8.4
8
*
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
+∞
8.4
8
*
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
+∞
8.4
8
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
12.4
8.2
14
12
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
23.1
8.1
11
5
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
8.1
30
79
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
8.1
64
295
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
9.0
8.0
16
19
F10.25
ICD-10 Finland
Alcohol dependence continuous use
10.0
7.9
15
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
7.8
90
509
F10.24
ICD-10 Finland
Alcohol depence active use
12.5
7.7
13
11
ZX120
NOMESCO Finland
Intravenous
4.2
7.5
28
74
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
7.5
41
148
C07AB02
ATC
metoprolol; systemic
2.9
7.4
49
202
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
11.5
7.4
13
12
I42.8
ICD-10 Finland
Other cardiomyopathies
+∞
7.3
7
*
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
+∞
7.3
7
*
1CX08
NOMESCO Finland
NA
+∞
7.3
7
*
N05CF01
ATC
zopiclone; oral
2.4
7.2
75
396
115
Kela drug reimbursment
Breast cancer
5.3
7.2
21
43
I47.1
ICD-10 Finland
Supraventricular tachycardia
31.2
7.2
9
*
Z3231
NOMESCO Finland
Registered nurse
2.5
7.2
62
299
C07AA07
ATC
sotalol; systemic
10.6
7.1
13
13
F10.09
ICD-10 Finland
Alcohol intoxication UNS
10.6
7.1
13
13
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
10.6
7.1
13
13
XF404
NOMESCO Finland
Ambulatory ECG
6.3
7.1
18
31
B01AF02
ATC
apixaban; oral
8.0
7.0
15
20
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
14.4
7.0
11
8
N05BA02
ATC
chlordiazepoxide; systemic
8.7
6.9
14
17
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
7.6
6.8
15
21
XFE00
NOMESCO Finland
Epicardial ultrasonography
23.4
6.7
9
*
M04AA01
ATC
allopurinol; systemic
3.2
6.7
37
134
L03AA02
ATC
filgrastim; parenteral
6.6
6.6
16
26
N05BA04
ATC
oxazepam; oral
2.6
6.6
54
250
R06.0
ICD-10 Finland
Dyspnoea
2.6
6.5
51
231
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.3
6.4
16
27
XF640
NOMESCO Finland
NA
11.5
6.4
11
10
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
+∞
6.3
6
*
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
+∞
6.3
6
*
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
+∞
6.3
6
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
+∞
6.3
6
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
6.3
6
*
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
+∞
6.3
6
*
I50
ICD-10 Finland
Heart failure
27.6
6.3
8
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
27.6
6.3
8
*
WX892
NOMESCO Finland
Monitored bed care
4.5
6.2
21
51
N05AA02
ATC
levomepromazine; systemic
4.9
6.2
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
59
178
4.14
17.80
7.9
4.5
mmol/l
1.1
1.0
0.82
54
166
(3000991) Gas panel - Venous blood
40
109
4.25
13.63
22.6
7.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
14
13
11.42
12.98
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
34
97
3.95
10.81
3.3
2.1
ug/l
8.4
4.7
0.50
34
89
(3003396) Base excess in Arterial blood by calculation
44
151
3.38
10.65
17.6
6.5
mmol/l
1.5
1.1
0.30
39
117
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
124
1693
0.40
10.03
4.8
4.4
mmol/l
4.6
4.7
0.52
109
1554
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
129
1728
0.40
9.79
5.5
4.9
mmol/l
2.7
2.8
0.82
115
1577
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
123
1680
0.41
9.78
4.8
4.4
mmol/l
1.3
1.4
1.71
108
1527
(3002032) Base excess in Venous blood by calculation
39
133
3.34
9.49
8.4
2.9
mmol/l
2.4
1.7
0.54
31
101
(3012544) pH of Venous blood
38
134
3.21
8.74
8.4
3.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
29
5.86
8.63
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
29
5.86
8.63
1.3
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
29
87
3.68
8.55
24.7
8.1
%
93.2
94.2
0.35
29
87
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
28
86
3.58
7.96
25.4
8.1
%
0.6
0.7
1.12
28
86
(3045788) Cell count panel - Pleural fluid
12
8
15.75
7.80
1.8
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
30
98
3.38
7.77
1.8
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
70
361
2.37
7.65
2.8
1.8
mg/l
2.7
3.0
0.63
61
309
(3023368) Bacteria identified in Blood by Culture
82
453
2.28
7.63
7.1
4.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
15
7.66
7.62
1.6
1.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
27
86
3.43
7.26
25.8
8.0
%
1.7
1.5
0.52
27
86
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
938
0.42
7.08
3.9
4.9
ug/l
1.9
2.7
0.83
42
838
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
124
1627
0.47
7.08
4.7
3.9
mmol/l
1.6
1.3
3.33
109
1473
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
39
158
2.78
6.98
15.2
5.1
u/l
238.6
249.3
0.23
39
149
(40761511) CBC panel - Blood by Automated count
144
1787
0.46
6.90
28.2
11.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
172
2.61
6.37
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40
172
2.61
6.37
1.9
1.7
—
—
—
0
0
(3020891) Body temperature
19
52
3.90
6.35
8.2
3.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
34
4.66
6.34
5.1
2.6
u/ml
0.3
0.3
—
9
15
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
125
1613
0.49
6.23
6.5
5.8
mmol/mol
43.2
40.1
1.99
112
1484
(3042936) Bacteria identified in Isolate by Culture
51
251
2.34
6.07
3.8
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
133
1675
0.49
6.00
5.2
4.5
mmol/l
6.5
6.0
1.98
120
1519
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
149
2.60
5.67
3.3
2.5
u/l
32.7
30.0
0.20
30
127
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
245
2.28
5.60
2.4
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
62
3.44
5.60
8.9
2.2
%
1.5
1.2
0.57
20
62
(3018677) aPTT in Platelet poor plasma by Coagulation assay
47
231
2.31
5.59
5.1
2.0
s
30.8
29.2
1.21
47
226
(1761868) Lipid panel - Serum or Plasma
29
620
0.39
5.57
3.1
2.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
31
127
2.67
5.41
23.3
7.2
g/l
125.5
122.2
0.35
31
122
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
41
753
0.44
5.38
3.2
4.3
%
21.5
21.5
0.00
15
386
(3014891) Appearance of Pleural fluid
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
75
463
1.93
4.85
5.9
3.8
ph
7.4
7.4
0.23
13
83
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
133
1640
0.53
4.80
33.4
11.8
ml/min/173m2
79.6
80.2
0.11
123
1332
(36304419) Bacteria [Presence] in Urine
73
449
1.93
4.76
3.2
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
89
597
1.81
4.36
3.8
2.3
ug/l
197.3
187.9
0.10
82
549
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
41
3.58
4.26
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
41
3.58
4.26
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
74
472
1.85
4.25
3.2
2.9
e6/l
0.7
0.6
0.20
62
341
(3018405) Lactate [Moles/volume] in Arterial blood
15
47
3.35
4.14
5.4
5.2
mmol/l
2.2
1.3
0.66
15
47
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
173
2.21
4.07
3.8
3.4
umol/l
16.4
9.1
0.46
28
156
(3032080) INR in Blood by Coagulation assay
88
599
1.77
4.04
19.7
4.7
inr
1.5
1.1
1.72
18
167
(3043409) Potassium [Moles/volume] in Arterial blood
13
38
3.57
3.96
6.1
4.3
mmol/l
4.2
3.8
2.43
13
38
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
95
2.58
3.95
1.4
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
11
7.49
3.89
1.4
1.5
mmol/l
5.3
6.0
—
8
11
(3007853) Bacteria identified in Skin by Aerobe culture
36
185
2.13
3.80
2.9
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
25
4.14
3.74
1.9
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
142
1680
0.58
3.66
36.1
12.3
mg/l
28.9
25.2
0.74
133
1296
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
26
3.98
3.56
1.8
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
553
0.49
3.43
2.4
3.0
ug/l
0.6
0.8
0.93
22
375
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
10
7.18
3.39
1.4
1.9
u/l
241.1
428.8
—
7
10
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
615
1.68
3.37
3.7
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
75
519
1.67
3.11
3.2
3.1
e6/l
28.5
77.8
1.35
62
388
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
34
3.35
3.10
1.5
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
16
5.14
3.08
1.6
1.9
%
89.0
90.0
—
8
16
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
70
478
1.68
3.04
3.1
2.0
u/l
181.6
186.0
0.06
70
450
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
69
2.58
3.04
36.9
7.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
288
1.80
2.98
3.1
2.8
e6/l
1.1
1.2
0.02
32
167
(3019060) Gas panel - Arterial blood
19
83
2.41
2.93
5.2
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
935
0.61
2.92
2.9
2.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
106
813
1.58
2.83
7.9
5.6
e9/l
0.6
0.6
1.04
93
700
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
376
1.69
2.79
4.1
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
107
833
1.54
2.62
8.0
5.6
e9/l
1.7
1.9
1.76
96
742
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
25
3.71
2.60
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
105
815
1.54
2.60
8.0
5.6
e9/l
0.0
0.0
0.10
93
709
(3044941) Cell count panel - Synovial fluid
8
20
4.11
2.59
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
44
2.83
2.59
1.4
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
81
594
1.57
2.58
3.6
3.6
e6/l
80.9
96.2
0.09
66
414
(3009542) Hematocrit [Volume Fraction] of Blood
129
1515
0.65
2.52
39.9
13.4
%
39.3
40.0
0.64
93
1074
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
16
4.48
2.49
1.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
783
1.53
2.49
15.9
5.9
mmol/l
1.2
1.2
3.07
85
670
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
27
3.43
2.42
2.1
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
27
3.43
2.42
1.9
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
12
5.10
2.41
2.5
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
69
495
1.57
2.39
3.5
3.6
u/l
48.1
30.8
1.79
64
479
(40758558) Short blood count panel - Blood
59
408
1.61
2.39
9.8
7.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
23
3.57
2.29
1.1
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
18
3.98
2.27
2.1
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
24
3.42
2.20
13.1
2.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
105
837
1.48
2.19
8.1
5.8
e9/l
0.1
0.2
4.13
93
742
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48
324
1.61
2.13
8.8
1.8
mg/l
2.3
1.4
0.53
36
261
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
8
25
3.28
2.11
1.3
1.1
u/ml
278.9
312.1
—
8
15
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
10
5.09
2.08
1.8
1.4
umol/l
15.6
13.4
—
5
10
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
2.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
2.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
10
5.09
2.08
2.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
127
1472
0.68
2.06
4.8
4.0
mu/l
2.0
1.9
0.34
118
1295
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
28
2.92
1.88
1.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
24
2.98
1.73
1.6
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
24
2.98
1.73
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
13
3.91
1.72
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
13
3.91
1.72
2.4
2.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
48
0.00
1.72
0.0
3.5
—
23.1
—
0
27
(42870588) Differential panel, method unspecified - Blood
70
537
1.44
1.70
8.1
5.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
105
1.88
1.69
1.4
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
114
955
1.39
1.68
12.7
9.6
e9/l
4.5
4.1
0.84
102
839
(3028271) Lactate [Moles/volume] in Capillary blood
6
19
3.21
1.67
1.7
1.9
mmol/l
2.0
1.5
—
6
19
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
19
3.21
1.67
1.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
216
1.62
1.66
2.0
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
160
0.42
1.61
2.0
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
67
516
1.43
1.58
4.5
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
93
1.90
1.56
1.9
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
96
1138
0.73
1.55
5.3
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
44
0.00
1.53
0.0
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
21
2.91
1.51
3.5
3.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
21
2.91
1.51
2.5
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
48
636
0.69
1.49
5.1
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
23
141
1.70
1.48
2.6
2.2
nmol/l
425.6
359.4
1.38
23
131
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
38
2.42
1.47
1.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
39
2.36
1.45
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
22
2.77
1.44
1.0
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
456
0.65
1.43
3.8
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
92
760
1.36
1.41
12.3
9.1
e9/l
0.0
0.0
0.15
72
619
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
278
1.49
1.37
3.3
3.0
e6/l
1.8
1.4
0.11
23
160
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
17
2.98
1.36
1.4
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
17
2.98
1.36
2.0
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
37
0.00
1.35
0.0
1.3
—
3.4
—
0
7
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
38
0.00
1.35
0.0
1.3
—
2.7
—
0
7
(3009261) Glucose [Presence] in Urine by Test strip
66
813
0.73
1.30
4.3
3.2
estimate
0.0
0.0
0.00
13
135
(3035637) Corticotropin [Mass/volume] in Plasma
5
18
2.82
1.29
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
44
2.09
1.28
2.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
35
2.33
1.28
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
99
1147
0.75
1.27
4.1
3.3
pmol/l
14.9
14.8
0.19
94
998
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
41
301
1.44
1.25
4.6
3.0
mmol/l
2.5
2.4
0.33
35
266
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
57
1.98
1.19
1.5
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
66
804
0.75
1.19
4.3
3.2
estimate
0.0
0.0
0.00
13
142
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
34
0.00
1.17
0.0
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
20
2.53
1.15
17.4
2.3
%
64.4
61.7
—
5
20
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
36
0.00
1.15
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
177
1.53
1.14
1.6
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
66
799
0.75
1.13
5.6
4.5
estimate
0.0
0.0
0.00
13
144
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
12
66
1.86
1.11
3.4
3.7
pmol/l
4.3
4.9
0.91
12
52
(3004588) Protein electrophoresis panel - Serum or Plasma
17
105
1.67
1.09
1.5
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
122
1.61
1.06
4.4
2.5
e9/l
70.9
75.3
0.19
14
92
(3013707) Erythrocyte sedimentation rate by Westergren method
109
1229
0.78
1.06
4.5
3.8
mm/h
19.8
12.0
2.94
103
1121
(3027008) Opiates [Presence] in Urine
9
46
2.00
1.05
2.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
46
2.00
1.05
2.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
46
2.00
1.05
2.1
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
22
2.30
1.04
2.4
1.3
pmol/l
103.8
77.6
—
5
22
(3015377) Calcium [Moles/volume] in Serum or Plasma
64
523
1.31
1.02
5.6
3.5
mmol/l
2.3
2.3
0.75
56
456
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
166
1.50
0.99
1.6
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
23
2.20
0.98
1.2
1.3
ug/l
17.6
16.7
—
5
23
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
37
1.92
0.95
1.9
1.6
—
—
—
0
0
(3013512) EKG study
38
487
0.74
0.94
7.0
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
127
1.54
0.92
5.2
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
29
2.10
0.90
1.5
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
43
1.89
0.88
2.3
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
53
431
1.30
0.87
3.3
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
72
613
1.26
0.83
6.1
2.6
ng/l
36.1
44.6
0.37
61
428
(3052851) Hemolysis interference index of Serum or Plasma
6
34
1.79
0.77
8.7
2.7
—
—
—
0
0
(4010399)
16
108
1.52
0.76
1.5
1.5
—
—
—
0
0
(4035726)
22
160
1.42
0.73
1.6
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
60
1.70
0.73
1.3
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
216
0.67
0.73
19.7
5.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
39
1.82
0.73
1.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
25
2.02
0.73
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
30
231
1.34
0.72
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
35
436
0.77
0.72
1.7
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
196
1.37
0.71
2.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
42
341
1.29
0.71
5.5
4.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
224
0.69
0.68
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
62
1.64
0.66
3.6
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
165
0.65
0.66
1.6
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
44
1.61
0.65
1.3
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
29
1.74
0.64
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
63
1.61
0.63
1.0
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
174
0.67
0.62
2.7
2.1
nmol/l
7.4
13.9
2.10
12
157
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
175
1.35
0.61
5.5
2.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
257.9
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
511.7
—
0
10
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
37.1
—
0
10
(3004616) Nuclear Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
90
0.55
0.57
2.4
3.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
55
1.47
0.56
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
37
1.64
0.56
1.8
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
36
432
0.80
0.55
5.4
3.3
estimate
0.0
0.0
0.50
12
140
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
38
1.59
0.54
1.7
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
38
1.59
0.54
2.2
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
108
1.42
0.54
5.3
2.7
ml/min/173m2
53.4
68.0
—
5
43
(40760888) Immunoglobulin light chains.free panel - Serum
6
40
1.51
0.52
1.0
4.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
104
956
1.16
0.51
13.9
3.9
mmol/l
6.9
6.8
0.32
99
885
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
45
1.57
0.49
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
12
165
0.71
0.48
7.4
3.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
13
94
1.41
0.47
4.1
2.3
kpa
5.0
5.0
0.03
13
87
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
83
755
1.16
0.46
5.9
3.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.8
2.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
56
1.44
0.43
2.6
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
25
302
0.81
0.42
1.2
1.3
g/l
3.4
2.6
—
9
178
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
135
1278
1.14
0.41
14.9
7.8
u/l
87.8
79.9
0.97
130
1190
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
61
1.32
0.40
4.8
2.3
mmol/l
24.1
24.5
—
8
56
(40768804) Tissue Pathology biopsy report
59
655
0.87
0.39
2.4
2.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
9
67
1.36
0.38
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
79
0.62
0.36
1.0
1.3
u/ml
397.6
151.0
—
5
74
(3020682) Albumin/Creatinine [Ratio] in Urine
49
546
0.87
0.34
4.2
3.8
mg/mmol
10.4
5.2
0.66
40
348
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
87
0.68
0.33
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
35
307
1.17
0.31
2.2
1.7
nmol/l
1204.0
1125.8
0.13
27
221
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
74
689
1.11
0.28
2.1
2.0
pmol/l
83.6
94.7
1.27
45
362
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
73
0.68
0.26
4.4
3.6
u/ml
185.3
423.4
—
5
63
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
33
370
0.87
0.26
1.9
1.7
pmol/l
455.3
18874598.2
0.50
23
302
(3022313) Gas panel - Capillary blood
9
72
1.26
0.26
4.3
2.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
38
1.32
0.23
1.6
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
104
1088
0.92
0.23
4.7
3.1
u/l
105.4
55.4
2.85
97
1015
(3021440) Promyelocytes/100 leukocytes in Blood
15
125
1.21
0.23
6.3
4.8
%
0.0
0.1
—
8
35
(3047181) Lactate [Moles/volume] in Blood
5
40
1.26
0.22
1.8
3.9
mmol/l
1.1
1.2
—
5
34
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
0.7
—
0
5
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
104
0.76
0.21
3.4
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(4062490)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
111
0.80
0.20
3.2
2.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
113
1172
0.93
0.19
6.4
3.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
53
1.14
0.19
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
53
1.14
0.19
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
53
1.14
0.19
1.5
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
14
119
1.19
0.18
5.5
4.8
%
0.0
0.0
—
7
29
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
14
121
1.17
0.15
4.4
4.0
mmol/l
1.2
1.2
1.97
14
111
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
243
0.90
0.14
1.0
1.2
iu/ml
17.6
40.6
—
6
77
(3000492) Spirometry study
15
170
0.87
0.14
1.7
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
180
0.88
0.14
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
108
0.83
0.13
2.2
2.5
—
13.8
—
0
6
(3017181) Myelocytes/100 leukocytes in Blood
15
133
1.14
0.12
6.3
4.6
%
0.4
0.8
—
8
38
(3025941) Bacteria identified in Stool by Culture
10
86
1.17
0.11
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
52
542
0.95
0.09
3.5
2.9
mmol/l
8.0
8.3
0.21
47
443
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
48
1.04
0.09
1.4
1.2
—
0.2
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
113
0.88
0.08
1.7
1.4
—
—
—
0
0
(4034850)
5
64
0.78
0.08
10.0
8.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
13
120
1.09
0.05
6.4
4.7
%
0.3
0.4
—
7
28
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
119
0.92
0.04
1.5
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
23
220
1.05
0.03
1.5
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
65
638
1.03
0.03
2.7
2.2
nmol/l
71.9
76.6
0.57
59
560
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
360
1.03
0.03
4.3
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
50
510
0.97
0.02
3.8
3.1
mg/l
82.0
158.4
0.26
42
327
(3031040) Bacteria [#/volume] in Urine by Automated count
104
1050
0.98
0.02
5.2
4.0
—
42.8
—
0
20
(36660697) Celiac disease serology panel - Serum
11
117
0.94
0.02
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
128
1.02
0.00
4.8
2.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
24
237
1.01
0.00
1.0
1.2
u/ml
1.1
13.2
—
7
90
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
73
0.96
0.00
1.4
1.4
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1549.8
—
0
5
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
10.3
—
879.3
—
0
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
30.7
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
8
84
0.95
0.00
2.6
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
80
1.00
0.00
1.6
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1346.8
—
0
6
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.4
—
109.2
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.5
—
18.1
—
0
6
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
55.3
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
55
0.91
0.00
1.4
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
9.2
—
0
7
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_CARDMSEC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CARDMSEC | 6.432 [4.18, 9.9] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.206 |
During the follow-up period (1.1.1998 — 31.12.2019), 110 out of 233 females with I9_CARDMSEC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CARDMSEC | 7.233 [5.83, 8.98] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 480 out of 782 males with I9_CARDMSEC died.
Mortality risk
Mortality risk for people of age
years, who have I9_CARDMSEC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.612% | 1.675% |
| 5 | 3.985% | 8.275% |
| 10 | 9.404% | 18.906% |
| 15 | 17.163% | 33.051% |
| 20 | 27.778% | 49.542% |
Relationships between endpoints
↥Index endpoint: I9_CARDMSEC – Cardiomyopathies, Secondary/extrinsic
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data